Why Cettire, Gold Road, Imugene, and Paladin Energy Shares Are Racing Higher

The Motley FoolJan 2 20:31 ET

First Aussie Doses Bring Imugene Major Step Closer to 'Quicker, Cheaper' Non-Hodgkin's Lymphoma Care

The Market HeraldJan 2 19:56 ET

Guess Which ASX Small Cap Stock Is Jumping on 'Significant Milestone'

The Motley FoolJan 2 19:28 ET

Imugene Says First Australian Patient Dosed in Lymphoma Trial

MT NewswiresJan 2 18:19 ET

ASX Preview: Australian Shares to Open Lower Amid Wall Street Losses

MT NewswiresJan 2 17:40 ET

Imugene Receives Substantial Capital Injection; Extends Cash Runway to End of 2025 in Support of Ongoing Trials

Investing.com Dec 23, 2024 17:10 ET